T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.86% |
| 2 | Healthcare | 16.8% |
| 3 | Consumer Discretionary | 15.02% |
| 4 | Technology | 13.29% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HR
401
DELISTED
Healthcare Realty Trust Incorporated
HR
| $226M | 0.05% |
7,468,359
+110,836
| +2% | +$3.38M |
|
|
AMT.PRB
402
DELISTED
American Tower Corporation
AMT.PRB
| $226M | 0.04% |
2,185,661
-33,700
| -2% | -$3.57M |
|
|
EQC
403
DELISTED
Equity Commonwealth
EQC
| $225M | 0.04% |
7,439,847
+2,384,327
| +47% | +$70.6M |
|
404
Acadia Realty Trust
AKR
$2.86B
| $222M | 0.04% |
6,787,194
-19,220
| -0.3% | -$642K |
|
405
Ironwood Pharmaceuticals
IRWD
$674M
| $222M | 0.04% |
17,299,953
+6,827,507
| +65% | +$86.2M |
|
406
EastGroup Properties
EGP
$11B
| $219M | 0.04% |
2,962,634
-173,705
| -6% | -$12M |
|
407
CoStar Group
CSGP
$13.4B
| $217M | 0.04% |
11,534,990
+2,962,320
| +35% | +$58.2M |
|
408
Haemonetics
HAE
$4.11B
| $217M | 0.04% |
5,401,931
-102,592
| -2% | -$3.87M |
|
|
NATI
409
DELISTED
National Instruments Corp
NATI
| $216M | 0.04% |
7,000,958
+163,296
| +2% | +$4.76M |
|
|
PF
410
DELISTED
Pinnacle Foods, Inc.
PF
| $214M | 0.04% |
3,996,607
+60,113
| +2% | +$3.05M |
|
411
Sempra
SRE
$56.5B
| $213M | 0.04% |
4,241,380
+3,300,616
| +351% | +$168M |
|
|
BUFF
412
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $212M | 0.04% |
8,827,299
-708,398
| -7% | -$17.1M |
|
413
Minerals Technologies
MTX
$2.26B
| $212M | 0.04% |
2,745,297
-291,082
| -10% | -$21.6M |
|
414
Factset
FDS
$10.2B
| $212M | 0.04% |
1,297,116
-826,030
| -39% | -$132M |
|
|
AVNS
415
DELISTED
Avanos Medical
AVNS
| $211M | 0.04% |
5,713,972
-109,196
| -2% | -$3.9M |
|
416
Sysco
SYY
$40B
| $211M | 0.04% |
3,814,189
-826,073
| -18% | -$42.9M |
|
417
Post Holdings
POST
$3.65B
| $210M | 0.04% |
3,985,741
-33,588
| -0.8% | -$1.7M |
|
418
RB Global
RBA
$16B
| $209M | 0.04% |
6,144,685
+213,740
| +4% | +$7.77M |
|
|
K
419
DELISTED
Kellanova
K
| $207M | 0.04% |
2,997,833
-20,395
| -0.7% | -$1.42M |
|
|
BLUE
420
DELISTED
bluebird bio
BLUE
| $203M | 0.04% |
253,846
-5,994
| -2% | -$4.76M |
|
421
White Mountains Insurance
WTM
$5.11B
| $202M | 0.04% |
241,454
-22,276
| -8% | -$18.7M |
|
422
Teledyne Technologies
TDY
$31.2B
| $201M | 0.04% |
1,630,347
+12,714
| +0.8% | +$1.47M |
|
423
S&P Global
SPGI
$125B
| $200M | 0.04% |
1,859,358
-507,138
| -21% | -$60.6M |
|
424
Macy's
M
$6.27B
| $197M | 0.04% |
5,509,136
-117,690
| -2% | -$4.58M |
|
|
CKH
425
DELISTED
Seacor Holdings Inc.
CKH
| $197M | 0.04% |
2,859,917
+55,458
| +2% | +$3.26M |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.